Editas Medicine, Inc. — Director's Dealing 2016

Oct 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-10-05

Reporting Person: Cox Gerald Frank (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-05	Stock Option (right to buy)	$15.48	A	225000	Acquired	2026-10-04	Common Stock (225000)	Direct

Footnotes

F1: This option was granted on October 5, 2016 and is scheduled to vest over four years with 25% of the shares scheduled to vest on October 3, 2017, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 3, 2020.